ãã«ã»ããã°ããªãŒãšäŒã£ãŠ

æ±äº¬ã§ããã¹ã£ãŠããŸããã
ãªãŒãã£ãšã³ã¹ã«æ¬§ç±³äººãããããšãæ³å®ããŠãã¹ã©ã€ãã¯å
šéšè±èªã§äœããŸãããå
容ãèªå·±ç޹ä»ãããã¯è±èªã§ãããããšæã£ãŠããŸããããäŒå ŽãèŠåããŠã»ãŒ100ïŒ
æ¥æ¬äººã ã£ãã®ã§ãäºå®å€æŽããŠãé æ
®ãªãæ¥æ¬èªã§ããã¹ããŸãã(ç¬)

ãã«ã»ããã°ããªãŒããã€ã³ã¿ãã¥ãŒãåããŸããã
忥ãã€ã³ã¿ãã¥ãŒãåããéµå·ããããç®ããããèŠãŠãã人ãã£ããåã®ãªã人ã俺ã®å¥œããªã¿ã€ãããããšèšã£ãŠãŠãéµå·ããã«ã奜ãããšèšããããªããŠãçžåœãªäººã ãªãšæã£ãŠãããã©ãå®éãã®éãã ã£ãã
ã€ã³ã¿ãã¥ãŒäžãåã®ç®ã®å¥¥ãŸã§èŠéããããã«ãæãã£ããç®ãçŽèŠããŠãã人ã§ãåã¯ã¡ãã£ãšåœæããŸãããããããã®ã¯æåã®å·®ãããã ãããã©ãããããã¯ããã«ã®äººéåã§ãããã€ã³ã¿ãã¥ãŒããçžæã®èšãããšããããšãåãæ¢ããããšããŠãç®ããããææ
ãèªã¿åãããšãããäžçãããã¬ãã«ã®ãžã£ãŒããªã¹ãã¯ãããã人ãããšæããŸããã
ããããäººçžæã ãšãè±èªãšãæ¥æ¬èªãšããèšèã®å£ã¯ããŸãé¢ä¿ãªãã§ãããçµå±ã人éåã®åè² ãšããããšã«ãªã£ãŠãããåã¯è±èªã¯å€å°ã§ãããã©ãéµå·ããã¯è±èªã¯å
šç¶åãããªããã§ããéµå·ããã®äººéãšããŠã®ã倪ããã¯ããã«ã«ã¯çµ¶å¯ŸäŒãã£ãŠããã¯ãã§ããåã¯ã圌ã®ç®ã®çŽèŠã«èããããŠãããã£ã¡ã
ãèŠç·ãå€ããã®ã§ããã£ããæåäžå¯©ã«èŠããããšæã(ç¬)
ãã«æ¬äººã«åã®æããäŒããããšãã§ãããªããŠããããªæ©äŒã¯æããä»åºŠäžçãªããããã§ããäžèŸã§ãäœã§ããªããåã¯ããããããšãèšããŸããããããªãã¯åã«ãšã£ãŠãäŒèª¬ã®äººãã§ããã¯ã¯ãã³ã®å±éºæ§ã«ã€ããŠã¯åã
ããç¥ã£ãŠã¯ããŸãããããããªåã§ãããããªãã®ããã¥ã¡ã³ã¿ãªãŒãVAXXEDããèŠãŠãè¡æãåããŸããããããã¯ã§ããã ãå€ãã®äººãèŠãã¹ãã ããšæã£ãŠãåç»ã®äžéšã翻蚳ããŠãåç»å
±æãµã€ãã®ããªãã¥ã·ãŒãã«ã¢ããããããšãããã»ã©ã§ãã
https://note.com/nakamuraclinic/n/n7795663d1980
ãããŠããã®ãã³ããŸãæ°ãã«ããã¥ã¡ã³ã¿ãªãŒãAn Inconvenient Studyããäœã£ãããããŸãè¡æã®åé¡äœã§ãããã®åç»ãäžçäžã®å»çåŸäºè
ãèŠãã°ãã¯ã¯ãã³æ¿çãå€ããã¯ãã§ããå®éã¢ã¡ãªã«ã§ã¯ãã±ããã£åçé·å®ãæ¹åã«åããŠåããŠããã
ãããªåé¡äœãäžã«åºããŠããã«ãããªãã¯å€§äžå€«ã§ããïŒãã®ã¯ã¯ãã³çéã§ã¯ãè£œè¬æ¥è
ã«ãšã£ãŠäžéœåãªååšã¯ããã°ãã°æ¶ãããŸãããããªããå¿é
ã§ãã
ã幞ãã«ããæ»ãªãã«æžãã§ãããç¥æ§ãèŠå®ã£ãŠãããŠããã®ãããããªããã
ãAn Inconvenient Studyãã®åææ¹æ³ã¯ããžã£ãŒããªã¹ãã®ç§ã«ã¯ããªã¹ããŒãªãã®ã ã£ããã ã£ãŠããå士ãšé£äºããŠãããã§åœŒã®æ¬é³ãåŒãåºããããããé ãæ®ãããŠãããã ãïŒãããããããæ¬äººã®èš±å¯ããªããäžã«åºããããžã£ãŒããªã¹ãã®æ¹æ³ãšããŠããŸã£ãšããªãã®ã§ã¯ãªããç§ã®è©å€ã«å·ãã€ããããããªããããã§ããç§ã¯ãããäžã«åºãããšãéžãã ãæ©ãŸãã倿ã ã£ããã
https://www.aninconvenientstudy.com/

åã®ä»åã®è¬æŒããŒãã¯ãã³ããã¯ã¯ãã³ããã³å°å
宿æ¥çš®ã¯ã¯ãã³ã®åŸéºçã®æ²»çãã§ãããã³ããã¯ã¯ãã³ãæã£ãåŸã«çãã諞çç¶ã«å¯ŸããŠããããã¯ãå°å
ã¯ã¯ãã³æ¥çš®åŸã®èªéçãšãADHDã«å¯ŸããŠãã©ã®ããã«æ²»çããã®ããåã®æ¹æ³ã玹ä»ããã®ã§ãããåã®èšåºã«ã¯ããªããšãã£ãŠããã²ã«ãããŠã ãæ¬ ãããŸããã
ãã«ã«ããã²ã«ãã®ãã°ãããããã¬ãŒã³ããããšããã®ã§ããããã«ã¯ããŸãæ²»çæ³ã«ã¯èå³ããªãããã§ãããããããŸãããã ããããè¬ã®æ±æŽäººãæªãããªãµããªã売ã蟌ãã§ãããã¿ããã«èŠããã ãããªã
ãšããããã³ããã¯ã¯ãã³åŸéºçã®æ²»çäŸã«ã€ããŠã²ãšã€ãããã§äŸèЧããŸãããã£ãããªã®ã§ãè¬æŒã§äœ¿ã£ãè±èªã¹ã©ã€ãããèŠãããŸãããã

20代女æ§ããã³ããã¯ã¯ãã³ã®2åç®ãæã£ãåŸãçºç±ãããé«ç±ã2é±éã»ã©ç¶ãããç
é¢ã«è¡ã£ãŠãããããªæ€æ»(PCRæ€æ»ãšãæ¡è¡ãšã)ãåãããã©ããç¹ã«ç°åžžãªãããšã®ããšã
2é±éãã£ãŠãé«ç±ã¯äžãã£ãããã©ã埮ç±ããã£ãšç¶ããŠãããåœé¢ã«åããŠæ¥ãããã®ã2023幎1æã ããã©ã埮ç±ãå»¶ã
ç¶ããŠãããç±ã ãã§ã¯ãªããŠããå¯ãã«åŒ±ããªã£ããããšãç
çã«ç²ãããããã¡ãã£ãšããéåãããšãã°é段ãäžããã ãã§æ¯ãäžããã»ã©ããã©ããç¡ç ã®è³ªãæªãã倧ããªé³ã匷ãå
ã«ç°åžžã«ææã«ãªã£ãŠãããã ãã§ç²ãããççåšæããããããã¿ãããªæãã§ãåŠãªäœèª¿äžè¯ããã£ãšç¶ããŠããã
ç±ã¯ççåšæã«å¯Ÿå¿ããŠããŠã

ã¯ã¯ãã³ãæã€åã¯ãã€ã36.5â以äžã ã£ãã®ããæ¥çš®åŸã¯ãççåã«ã¯37床å°åŸåãççäžã¯37床ååãççãçµãããš36床å°åŸåããšããå
·åã§ããã€ãã ããã埮ç±ãããã
ãããççåšæã¯ä¹±ããã¡ã§ãççåã®ã€ã©ã€ã©ã匷çã«ãªãã飿¬²ãç°åžžã«äº¢é²ããã

å¯ãã«ç°åžžã«åŒ±ããªããããšãã°ã宀枩ã27âã§ãå¯ããæè¶³ãå·ããŠãé¡è²ãæªãã颚åã«å
¥ã£ãŠãããããã·ã«ãªãã
ç°æ§ãªç²åŽæã§ãã¡ãã£ãšåãã ãã§ç±ãäžããããŸãšãã«ä»äºãã§ããªãã®ã§ããªã¢ãŒãå€åã«å€ããŠããã£ãã»ã©ãããŸãã«ãç²ããã®ã§ãå€åäžã«æŒå¯ãããªãããããªãã»ã©ã«ãªã£ãã

ç¡ç ã®è³ªãæªããããã£ã¡ã
ãäžéèŠéãããå°ãã§ãç¡ç ã®è³ªãé«ããããã«ãè³æ ãšã¢ã€ãã¹ã¯ãããŠããã
ããšããšåäŸã®ãšãããèãæªããšææãããŠããããã©ãæ¥çš®åŸãç¹ã«å¬ã®å¯ãææã«ã¯ãèã«é»æçãèµ°ã£ãããèãæ²ããããšããé£ãããªã£ãã
ããŠãããã ããæºèº«åµçãã®äººããã²ã«ãããŠã ãšDMSOãæçšãå§ãããšãããã©ã®ãããªå€åãèµ·ãã£ããïŒ


æ£è
ã¯ãåçã«å¹ããããšçããŸããã
ãã²ã«ãããŠã ã飲ããšã確ãã«ç±ãäžããã2幎éãã£ãšç¶ããŠãã埮ç±ãäžãã£ãã®ã§ãä¿¡ããããªããããã§ããã£ãããããŠäžæ¢ããŠã¿ãããããšããã£ã±ããŸã埮ç±ãæ»ã£ãŠãããããã§ã²ã«ããå¹ããŠããã ãªãšç¢ºãã«å®æããã
DMSOãåãã§ãã飲ããšãã²ã«ããšãããŸã£ãŠã確ãã«ç±ãå¹³ç±ã«æ»ããå®éšçã«äžåãããŠã¿ããšã確ãã«ãŸãç±ãæ»ã£ãŠãããããã§ã確信ããŸããã確ãã«ãã²ã«ããšDMSOãå¹ããŠãããšã
ã¡ãã£ãšåããã ãã§æ¯åãããŠãè¶£å³ã楜ããããšãã§ããªãã£ãã®ããä»ã§ã¯é±æ«ã«å€åºãããããµã€ã¯ãªã³ã°ã«åºããããããããšãã§ããããã«ãªããŸããã
ãã€ããã¯ã¯ãã³åŸéºçããã²ã«ããšDMSOã®ãããã§èŠäºã«ã³ã³ãããŒã«ãããããã§ãã
ã²ã«ããšDMSOã¯ãçžå çã«ãšããããã¯ãçžä¹çã«å¹ããŠããå°è±¡ãåããŸãã
ãšããã§ãããããçãããDMSOãšããã®ããåç¥ã§ããããã
åã®éå»èšäºã§ããã¡ããã¡ããèšåããŠããŸããããããŸã詳ãã玹ä»ããããšã¯ãªãã£ããããããŸããã

DMSOã¯ããžã¡ãã«ã¹ã«ããã·ãã®é æåã§ããããã«ããååŠç©è³ªããšããååãªã®ã§åŒããŠããŸããããããŸãããããã¿ãã³Cãšåããããã«å®å
šãªã®ã§ããªã¹ã¯ã¯ã»ãŒçç¡ã§ãã飲ãã®ã¯ãã¡ãããç¹æ»Žã§å
¥ããŠãããããç®è¬ã«ããŠãããããã ãã¡ãã£ãšã«ãããç¬ç¹ã§ããæµ·ã«è¡ã£ããšãã«ããæµ·ã®ã«ããããæããã§ããïŒãã®ã«ãããããŸããã磯ã®éŠãããšè¡šçŸããããããªãç¬ç¹ã®ã«ããã§ãååæ§é ã®ãªãã«ïŒ³(ç¡«é»)ãå«ãç©è³ªã«ã¯ãããããããšããããããŸãã
广ã¯ãççãé®ããŠãçã¿ããšã£ãŠãããŠãè¡ããµã©ãµã©ã«ããŠãå€ãªèãšãã¿ã³ãã¯ããã£ã€ããŠãããŠãçã«ãå¹ãããšããå
·åã«å€æ§ã§ãã
å¹ãç
æ°ãæ°ãã ãã°åãããªããã©ã

è³å åºè¡ãè髿å·ã麻çºãå¿èçºäœãèªç¥çãã¢ããã€ããŒã·ã¹ãçºéé å»¶ãããŠã³çã粟ç¥é害ãã¬ã€ããŒçãéèç€ãæ ¢æ§çŒçãªã©ãæ°ããããŸããã

ãã€ãã¿ãŒã«ãDMSOã飲ã¿å§ããå·Šç®ãç²ç®ã®ç·æ§ããç®ãèŠããããã«ãªã£ããšããæçš¿ããããŸããããŸããããããå¥è·¡ãèµ·ããç©è³ªã§ãããããã§ãã

ããšããšã1960幎ã«ãšããå€ç§å»ãããã®æå¹æ§ã«æ°ä»ããŸããããã€ã±ãã«å¹ããããæ«ã«å¹ããé¢ç¯çã«å¹ãããããå¯äœçšããªããããã¯ãããããšããããšã§ããŸããããŸã«è©å€ã«ãªããNTã¿ã€ã ãºçŽã¯ã60幎代ãçãã å¥è·¡ã®è¬ããšå ±éããŸããã
ããããæ¬ç©ããåºããšãããããŸæå§ãããŸããFDAïŒè£œè¬äŒç€Ÿã®å©çãå®ãå£äœïŒããã䜿ããªããšèšãåºãããããã«ããç ç©¶ãããªããšèšããããã«ããå€åœã«ã茞åºãããªããšèšãåºããã
DMSOã¯ãããšããšã¯è£œçŽæ¥ã§ãæšæãããã«ãã補é ãããšãã«çããå¯ç£ç©ãªã®ã§ã倿®µã¯ã¢ãã¿ããã«å®ããããããå¯ç£ç©ãšããŠçããåã«ã¯ä»æ¹ãªãããåæ³ã«ãããã©ããã§ããããå»ççšã«äœ¿ã£ãã絶察ã¢ã«ã³ãïŒããšãããµãã«FDAã¯ãã¬ãã·ã£ãŒããããã
ã§ãããåœæ°ã¯ãã£ãã䜿ãç¶ãããã ã£ãŠãå¹ããã ãã®ã䜿çšè
ã®98ïŒ
ããçã¿ãæ¶ããããšæå¹æ§ã宿ããŠããããããããããœãã³ã®ãããªå¯äœçšããªãããããããã£ãã䜿ãããã

1960幎代ããµãªããã€ãçŠããã£ããã«ãFDAã«è¬ã®èš±èªå¯æš©ãšããã匷åãªåãäžããããã
ãDMSOãšãããã°ãããç©è³ªãããããããããè¬ãšããŠèªå¯ããŠæ¬²ããããããã声ã¯FDAã«ãåœç¶å±ããŠããããããFDAã¯ãå®è³ªçã«ã¯ãæ¢åã®è£œè¬äŒç€Ÿã®å©çæè·å£äœã§ãããã ããããããªåªç§ãªç©è³ªãè¬ãšããŠèªå¯ãããŠã¯ãæ¢åã®è¬ããã¹ãŠç¡æå³åããŠããŸãããšããŠãFDAã®è¬ãžã®ç³è«ã¯ãã¹ãŠåŽäžãããã
DMSOã¯ãã·ã¢ããŠã¯ã©ã€ãã§ã¯è¬ãšããŠæ£åŒã«èªããããŠãããããããã¢ã¡ãªã«ã§ã¯ãããããçç±ã§ãè¬ãšããŠèªå¯ãããªãã£ãããšãããã人ã
ã®éãããã£ããå¿ããããŠããŸã£ãã
ããããããŸãããããã®æä»£ã§ããããã¬ãã®ãã¥ãŒã¹å ±éã¯ãããã§ãæ
å ±èŠå¶ã§ãããããããã«ããæ
å ±æ¡æ£ã¯æ¢ããããªãããšããããã³ããçŠããã£ããã«ã人ã
ã¯ãè£ãèªããããã«ãããªã£ãŠããŸã£ãããã³ããã¯ã¯ãã³ãšãæçå€ãšããæ¿åºãå§ããŠãããã®ã«ã¯ãã¯ãªãã®ããªããããããã¯ãæ¿åºãããã¡ããšãããã®ãããæ¬ç©ãªããããªãã®ãããšã
å®éãDMSOããã®ã²ãšã€ãªãã ããã
FDAã¯DMSOãããã«å±éºã§æããããã®ããšäž»åŒµããããã©ããå®éã®äœ¿çšè
ã®å£°ã¯ãããã§ã¯ãªããDMSOã¯ãã®æããäŸãšããããšã«ãªããŸãã
åãããå幎ã»ã©ãèªåãå«ããããªãã®æ£è
ã«DMSOãå§ããŠããŠããã®ãã£ãŒãããã¯ãããã¶ãããŸã£ãŠããŸããããŸãã®æ©äŒã«ç޹ä»ããŸãã